All News #Library
Biotech
Earendil Labs Doses First Patient in Phase IIa HXN-1001 UC Trial
02 Apr 2026 //
PR NEWSWIRE
Earendil Labs Secures $787M To Expand AI-Driven Biologics R&D
20 Mar 2026 //
PR NEWSWIRE
Earendil Labs starts phase 1 study of extended anti-TL1A antibody
11 Jul 2025 //
PR NEWSWIRE
Sanofi pens $1.8B deal for 2 autoimmune, immunology bispecifics
17 Apr 2025 //
FIERCE BIOTECH

Market Place
Sourcing Support